⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 12, 2024

Figure S4 from Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer

Takahiko Murayama Navin R. Mahadevan Catherine B. Meador Elena V. Ivanova Yuqiao Pan Erik H. Knelson Tetsuo Tani Jun Nakayama Xueying Ma Tran C. Thai Yin P. Hung William Kim Hideo Watanabe Kathy Q. Cai Aaron N. Hata Cloud P. Paweletz David A. Barbie Israel Cañadas

View at Publisher

Ask AI

Bookmark

Share

Abstract

Figure S4 shows TREX1 depletion increases sensitivity of resistant SCLC cells to chemotherapy

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Murayama et al. (2024) studied this question.

synapsesocial.com/papers/68e58bb0b6db643587527dc9 https://doi.org/10.1158/2767-9764.27004122

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S1 from Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer2024
2Figure S2 from Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer2024
3Figure S5 from Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer2024
4Figure S3 from Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer2024
5Table 1 from Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer2024

More related papers

Table 1 from Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer2024
Data from Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer2024
Figure 5 from Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer2024